Project Results for Measuring Analytes in Maternal Archived Samples (MAMAS) – MAMAS 3
Project: Measuring Analytes in Maternal Archived Samples (MAMAS) – MAMAS 3
- Study Group: 300 pregnant individuals
- Sample Collection Date: -
Chemical Group: Organochlorine Pesticides
- Measured in: Serum
- Study Group Subset: Subsample 1
Unweighted Results
| Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||
| beta-Hexachlorocyclohexane (beta-HCH) | b-HCH | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | 4.12 | 17.6% | 0.0160 ng/mL |
| DDE (para,para) | para,para-DDT and/or para,para-DDE | ng/g lipid | 204 | 11.1 | 9.59 | 12.9 | 4.71 | 9.50 | 18.4 | 97.1 | 75.5% | 0.0320 ng/mL |
| DDT (ortho,para) | ortho,para-DDT | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0160 ng/mL |
| DDT (para,para) | para,para-DDT | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 3.4% | 0.0160 ng/mL |
| Hexachlorobenzene (HCB) | HCB | ng/g lipid | 204 | 10.3 | 10.0 | 10.6 | 8.99 | 10.2 | 11.7 | 14.0 | 100% | 0.0230 ng/mL |
| Oxychlordane | Chlordane | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0160 ng/mL |
| trans-Nonachlor | Chlordane | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.5% | 0.0160 ng/mL |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
Chemical Group: Perfluoroalkyl and Polyfluoroalkyl Substances (PFASs)
- Measured in: Serum
- Study Group Subset: Subsample 2
Unweighted Results
| Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 90th | |||||||
| 4:2 FTS | 4:2 FTS | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0372 ng/mL |
| 5:3 FTCA | 5:3 FTCA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 7.3% | 0.0500 ng/mL |
| 6:2 diPAP | 6:2 diPAP | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0645 ng/mL |
| 6:2 FTCA | 6:2 FTCA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 4.2% | 0.250 ng/mL |
| 6:2 FTS | 6:2 FTS | ng/mL | 87 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.188 ng/mL |
| 6:2 FTUCA | 6:2 FTUCA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0243 ng/mL |
| 6:6 PFPiA | 6:6 PFPiA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0429 ng/mL |
| 6:8 PFPiA | 6:8 PFPiA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.0% | 0.198 ng/mL |
| 7:3 FTCA | 7:3 FTCA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0622 ng/mL |
| 8:2 diPAP | 8:2 diPAP | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.250 ng/mL |
| 8:2 FTCA | 8:2 FTCA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.250 ng/mL |
| 8:2 FTS | 8:2 FTS | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.1% | 0.0500 ng/mL |
| 8:2 FTUCA | 8:2 FTUCA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0280 ng/mL |
| Et-PFOSA-AcOH | Et-PFOSA-AcOH | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | 0.0136 | 11.5% | 0.0131 ng/mL |
| Me-PFOSA-AcOH | Me-PFOSA-AcOH | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 22.9% | 0.0638 ng/mL |
| PFBA | PFBA | ng/mL | 96 | 0.0760 | 0.0697 | 0.0828 | 0.0645 | 0.0845 | 0.0990 | 0.117 | 82.3% | 0.0500 ng/mL |
| PFBS | PFBS | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 7.3% | 0.0140 ng/mL |
| PFDA | PFDA | ng/mL | 96 | 0.187 | 0.160 | 0.220 | 0.109 | 0.169 | 0.285 | 0.613 | 99.0% | 0.0542 ng/mL |
| PFDoA | PFDoA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | 0.0741 | 17.7% | 0.0500 ng/mL |
| PFDS | PFDS | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 6.3% | 0.0274 ng/mL |
| PFHpA | PFHpA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.1% | 0.0107 ng/mL |
| PFHxA | PFHxA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.108 ng/mL |
| PFHxPA | PFHxPA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 ng/mL |
| PFHxS | PFHxS | ng/mL | 96 | 0.416 | 0.366 | 0.473 | 0.272 | 0.386 | 0.606 | 0.951 | 100% | 0.0472 ng/mL |
| PFNA | PFNA | ng/mL | 96 | 0.406 | 0.360 | 0.457 | 0.263 | 0.426 | 0.564 | 0.830 | 100% | 0.0767 ng/mL |
| PFOA | PFOA | ng/mL | 96 | 0.892 | 0.783 | 1.02 | 0.604 | 0.895 | 1.29 | 2.00 | 100% | 0.0539 ng/mL |
| PFOPA | PFOPA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 ng/mL |
| PFOS | PFOS | ng/mL | 96 | 2.39 | 2.08 | 2.75 | 1.47 | 2.47 | 3.56 | 5.42 | 100% | 0.316 ng/mL |
| PFOSA | PFOSA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0173 ng/mL |
| PFPeA | PFPeA | ng/mL | 96 | * | * | * | <LOD | <LOD | <LOD | <LOD | 5.2% | 0.0235 ng/mL |
| PFUnDA | PFUnDA | ng/mL | 96 | 0.121 | 0.0990 | 0.147 | 0.0584 | 0.108 | 0.215 | 0.532 | 79.2% | 0.0481 ng/mL |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
Chemical Group: Polybrominated Diphenyl Ethers (PBDEs)
- Measured in: Serum
- Study Group Subset: Subsample 1
Unweighted Results
| Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||
| BDE 017 | BDE 17 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0160 ng/mL |
| BDE 028 | BDE 28 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0160 ng/mL |
| BDE 047 | BDE 47 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | 4.05 | 8.30 | 34.8% | 0.0240 ng/mL |
| BDE 066 | BDE 66 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0160 ng/mL |
| BDE 085 | BDE 85 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0160 ng/mL |
| BDE 099 | BDE 99 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | 4.80 | 11.7% | 0.0220 ng/mL |
| BDE 100 | BDE 100 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | 2.66 | 5.4% | 0.0160 ng/mL |
| BDE 153 | BDE 153 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | 13.8 | 24.5% | 0.0320 ng/mL |
| BDE 154 | BDE 154 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0320 ng/mL |
| BDE 183 | BDE 183 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0320 ng/mL |
| BDE 196 | BDE 196 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0320 ng/mL |
| BDE 197 | BDE 197 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.5% | 0.0320 ng/mL |
| BDE 201 | BDE 201 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0320 ng/mL |
| BDE 202 | BDE 202 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0320 ng/mL |
| BDE 203 | BDE 203 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0320 ng/mL |
| BDE 206 | BDE 206 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.5% | 0.0400 ng/mL |
| BDE 207 | BDE 207 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.0% | 0.0400 ng/mL |
| BDE 208 | BDE 208 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.5% | 0.0400 ng/mL |
| BDE 209 | BDE 209 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.5% | 0.300 ng/mL |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
Chemical Group: Polychlorinated Biphenyls (PCBs)
- Measured in: Serum
- Study Group Subset: Subsample 1
Unweighted Results
| Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||
| PCB 066 | PCB 66 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0160 ng/mL |
| PCB 074 | PCB 74 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.0% | 0.0160 ng/mL |
| PCB 099 | PCB 99 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.0% | 0.0160 ng/mL |
| PCB 101 | PCB 101 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0160 ng/mL |
| PCB 105 | PCB 105 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0160 ng/mL |
| PCB 118 | PCB 118 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.0% | 0.0160 ng/mL |
| PCB 138 | PCB 138 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | 2.80 | 8.3% | 0.0160 ng/mL |
| PCB 153 | PCB 153 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | 2.44 | 4.40 | 27.0% | 0.0160 ng/mL |
| PCB 156 | PCB 156 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.0% | 0.0160 ng/mL |
| PCB 170 | PCB 170 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | 2.66 | 5.4% | 0.0160 ng/mL |
| PCB 180 | PCB 180 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | 3.44 | 6.90 | 44.6% | 0.0160 ng/mL |
| PCB 183 | PCB 183 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0160 ng/mL |
| PCB 187 | PCB 187 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 4.4% | 0.0160 ng/mL |
| PCB 194 | PCB 194 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | <LOD | 3.4% | 0.0160 ng/mL |
| PCB 203 | PCB 203 | ng/g lipid | 204 | * | * | * | <LOD | <LOD | <LOD | 3.08 | 18.6% | 0.0160 ng/mL |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.